Clinical Trial Update: Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on fecal microbiota transplantation in relapsing multiple sclerosis has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Autoimmune Diseases, Relapsing Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2019-12-02